OptimizeRx Sets Fourth Quarter and Full Year 2025 Financial Results Conference Call for March 5, 2026, at 4:30 p.m. ET
OptimizeRx (Nasdaq: OPRX) will host a conference call on Thursday, March 5, 2026 at 4:30 p.m. ET to discuss fourth quarter results for the period ended December 31, 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
OptimizeRx (Nasdaq: OPRX) will host a conference call on Thursday, March 5, 2026 at 4:30 p.m. ET to discuss fourth quarter results for the period ended December 31, 2025. A press release with the financial results will be issued before the call.
Access details include toll-free and international numbers, a webcast link, Conference ID 10206362, and a Call Me™ option. A replay will be available for 12 months in the company’s investors section.
Details
News Market Reaction – OPRX
On Feb 5, the day this news came out, OPRX closed 4.36% below the previous close.
Data tracked by StockTitan Argus for the Feb 5 session.
Key Figures
- Conference date
- March 5, 2026
- Q4 and full-year 2025 results call
- Start time (ET)
- 4:30 p.m.
- Earnings conference call start time
- Toll-free number
- 1-844-825-9789
- US dial-in for conference call
- International number
- 1-412-317-5180
- International dial-in for conference call
- Conference ID
- 10206362
- Identifier for accessing the call
- Call Me passcode
- 6586380
- Passcode for Call me™ link
- Replay duration
- 12 months
- Replay available on investor website
Previous Conferences,earnings Reports
-
Scheduled Q1 2025 earnings call with management presentation and Q&A.
-
Announced Q4 and full-year 2024 results conference call timing.
-
Set date for Q3 2024 results call with webcast and replay access.
-
Announced Q2 2024 conference call and pre-call earnings release plan.
-
Provided business update and set date for Q1 2024 earnings call.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
WALTHAM, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, will hold a conference call on Thursday, March 5, 2026, at 4:30 p.m. Eastern Time to discuss its results for the fourth quarter period ended December 31, 2025. The financial results will be issued in a press release prior to the call.
OptimizeRx management will host the call, followed by a question-and-answer period. Details for the conference call can be found below:
| Date: | Thursday, March 5, 2026 |
| Time: | 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) |
| Toll Free: | 1-844-825-9789 |
| International: | 1-412-317-5180 |
| Conference ID: | 10206362 |
| Call me™ Link: | https://callme.viavid.com/?$Y2FsbG1lPXRydWUmcGFzc2NvZGU9JmluZm89Y29tcGFueSZyPXRydWUmYj0xNg== |
| Call me™ Passcode: | 6586380 |
| Webcast: | https://viavid.webcasts.com/starthere.jsp?ei=1750927&tp_key=099094fd29 |
Please call the conference telephone number or log on to the web access link five minutes prior to the start time.
A replay of the call will remain available for 12 months via the investors section of the OptimizeRx website at http://www.optimizerx.com/investors.
About OptimizeRx
OptimizeRx is a leading healthcare technology company that’s redefining how life sciences brands connect with patients and HCPs. Our platform combines innovative, AI-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood® audiences to deliver timely, relevant, and hyper-local engagement. By bridging the gap between HCP and direct to consumer (DTC) strategies, we empower brands to create synchronized marketing solutions that drive faster treatment decisions and improved patient outcomes.
Our commitment to privacy-safe, patient-centric technology ensures that every interaction is designed to make a meaningful impact, delivering life-changing therapies to the right patients at the right time. Headquartered in Waltham, Massachusetts, OptimizeRx partners with some of the world’s leading pharmaceutical and life sciences companies to transform the healthcare landscape and create a healthier future for all.
For more information, follow the Company on LinkedIn or X, or visit www.optimizerx.com.
OptimizeRx Contact
Andy D’Silva, Chief Business Officer
adsilva@optimizerx.com
Investor Relations Contact
Steven Halper
LifeSci Advisors, LLC
shalper@lifesciadvisors.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.